Cargando…
Efficacy and toxicity outcomes for patients treated with focal salvage high dose rate brachytherapy for locally recurrent prostate cancer
INTRODUCTION: Isolated local recurrence of prostate cancer following primary radiotherapy or brachytherapy may be treated with focal salvage high dose rate brachytherapy, although there remains an absence of high quality evidence to support this approach. METHODS: Men with prostate cancer treated co...
Autores principales: | Slevin, Finbar, Hodgson, Samantha, Rodda, Sree Lakshmi, Bownes, Peter, Bottomley, David, Adiotomre, Ese, Al-Qaisieh, Bashar, Dugdale, Emma, Hulson, Oliver, Mason, Joshua, Smith, Jonathan, Henry, Ann M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186261/ https://www.ncbi.nlm.nih.gov/pubmed/32368626 http://dx.doi.org/10.1016/j.ctro.2020.03.010 |
Ejemplares similares
-
Response to ‘Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer’
por: Slevin, Finbar, et al.
Publicado: (2020) -
A comparison of outcomes for patients with intermediate and high risk prostate cancer treated with low dose rate and high dose rate brachytherapy in combination with external beam radiotherapy
por: Slevin, Finbar, et al.
Publicado: (2019) -
Ten-year longitudinal health-related quality of life following iodine-125 brachytherapy monotherapy for localized prostate cancer
por: Slevin, Finbar, et al.
Publicado: (2020) -
Importance of dynamic contrast enhanced magnetic resonance imaging for targeting biopsy and salvage treatments after prostate cancer recurrence
por: Mason, Josh, et al.
Publicado: (2018) -
Hemiablative Focal Low Dose Rate Brachytherapy: A Phase II Trial Protocol
por: Fernandez Ots, Ana, et al.
Publicado: (2016)